Thirty Madison Stock
Thirty Madison is a patient-first health company bringing specialized care and treatment to people with chronic conditions.
Sign up today for more details and to buy or sell Thirty Madison Stock
Buy + SellThirty Madison Funding
Gain insight into Thirty Madison funding rounds, the table below shows Thirty Madison capital raises and the dates of Thirty Madison financing history.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
May 05, 2017 | Seed | $2.75M | ||
Nov 14, 2017 | Seed | $5.00M | ||
Aug 07, 2018 | Series A | $15.25M | ||
Mar 17, 2020 | Series B | $25.00M | ||
Aug 14, 2020 | Series B | $8.85M | ||
Aug 14, 2020 | Series B | $4.99M | ||
Aug 14, 2020 | Series B | $8.16M | ||
May 18, 2021 | Series C | $141.00M |
See Valuations and Financials
Gain insights Into Thirty Madison Stock Valuation + Share Prices
Get started to view real-time data on Thirty Madison stock including most recent valuation and historical share price information.
Get StartedThirty Madison Management Team
Co-Founder, CEO, Director
Steven Gutentag
Director
Randy Scott
Director
Regina Benjamin
Co-Founder, COO, Director
Demetri Karagas
President
Michelle Carnahan
Director
Andrew Weissman
Chief Business Officer
Caroline Hofmann
Chief Medical Officer
Neil Parikh
Chief Technology Officer
Gil Shklarski
Chief People Officer
Chelsea Trombino
Director
Amy Schulman
Chief Financial Officer
Quan Zhang
Director
Jason Stoffer
Thirty Madison Major Investors
Maveron LLC
Northzone Ventures AS
Greycroft Partners LLC
Steadfast Capital
First Round Capital
Two River
HealthQuest Capital
Mousse Partners, Ltd.
Bracket Capital
Polaris Partners
Johnson & Johnson Development Corp (JJDC)